Skip to main content
Article
Change in hematologic indices over time in pediatric inflammatory bowel disease treated with azathioprin
Drugs in R and D
  • Sherman Soman, Sheffield Children's Hospital
  • Dhandapani Ashok, Sheffield Children's Hospital
  • Sally A. Connolly, Sheffield Children's Hospital
  • Samantha J. Cordell, University of Warwick
  • Chris J. Taylor, Sheffield Children's Hospital
  • David I. Campbell, Sheffield Children's Hospital
Document Type
Article
Publication Date
12-1-2010
URL with Digital Object Identifier
10.2165/11539930-000000000-00000
Abstract

Azathioprine leads to changes in mean corpuscular volume (MCV) and white blood cell (WBC) indices reflecting efficacy or toxicity. Understanding the interactions between bone marrow stem cells and azathioprine could highlight abnormal response patterns as forerunners for hematologic malignancies. This study gives a statistical description of factors influencing the relationship between MCV and WBC in children with inflammatory bowel disease treated with azathioprine. We found that leukopenia preceded macrocytosis. Macrocytosis is therefore not a good predictor of leukopenia. Further studies will be necessary to determine the subgroup of patients at increased risk of malignancies based on bone marrow response. © 2010 Soman et al., publisher and licensee Adis Data Information BV.

Citation Information
Sherman Soman, Dhandapani Ashok, Sally A. Connolly, Samantha J. Cordell, et al.. "Change in hematologic indices over time in pediatric inflammatory bowel disease treated with azathioprin" Drugs in R and D Vol. 10 Iss. 4 (2010) p. 213 - 217
Available at: http://works.bepress.com/dhandapani-ashok/7/